

ACoA: Rethinking APS with the Guidance of New Classification Criteria
Nov 14, 2023
Award-winning researcher, Dr. Doruk Erkan, discusses new classification criteria for Antiphospholipid Syndrome (APS), highlighting the challenges of diagnosis and the need for further research. The podcast explores the complexity of APS, emphasizes the importance of assessing the antiphospholipid antibody profile, and discusses the limitations of the old criteria. The development of the new classification criteria is discussed, emphasizing the collaborative effort and point-based system. The podcast also touches on the challenges of APS guidelines, the development of criteria for patients needing anticoagulation, and the potential impact on diagnosis and management of ANIFOSFELIPIT syndrome.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Understanding Antiphospholipid Syndrome (APS)
02:19 • 18min
New 2023 Classification Criteria for Antiphospholipid Syndrome (APS)
20:27 • 10min
Development of New Classification Criteria for APS
30:01 • 28min
The Future of APS Guidelines and Research
58:30 • 5min
Development of New Classification Criteria for Patients Needing Anticoagulation
01:03:52 • 2min
2023 Classification Criteria for ANIFOSFELIPIT Syndrome
01:06:18 • 2min